The findings of the present study demonstrate and discuss the DNA sensor cGAS and cyclic GMP–AMP receptor stimulator of interferon genes (STING) as potential new targets for novel therapeutic approaches based on immune checkpoint inhibitors in microsatellite unstable stage IV colorectal cancer. The gene discussed is CGAS; the disease is colorectal cancer.